Video: Closure of Kabco Shows FDA's Power
May 15, 2013
FDA ordered contract manufacturer Kabco Pharmaceuticals to halt production of dietary supplements until it proves its facilities are compliant with GMPs (good manufacturing practices). This follows a warning letter FDA sent the company in 2010 regarding its GMP violations. Anthony Young an attorney at Kleinfeld, Kaplan and Becker, reviewed the consent degree provides some perspective from the SupplySide MarketPlace show floor.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like